You are currently browsing the category archive for the ‘STRONG signal’ category.

Enodis (ENO, 172.5p) is a nice little mover, and not new to bid rumours. Its directors seem to consistently take advantage of any setbacks in the share price.

To see if a pattern has been established, let’s go back a couple of years, to January 2006:

Jan ’06- Mike Cronk (non exec) and David McCulloch (ceo) both buy 50k shares each, at prices between 133p and 136p.

June ’06- Enodis reaches 215p (on news of discussions with Manitowic ticker: MTW)

August ’06- Peter Brooks(non exec and chairman) and Mike Cronk buy 38k shares between them at 171-172p

Jan ’07- Mike Cronk buys another 50k at 208p

Feb ’07- Enodis trades up to high of 223p (despite co rejecting AGA bid approach in Nov 06)

Sept ’07- Peter Brook buys 30k shares at 175p

Oct ’07- Enodis trades up to 215p on more bid rumours (supposedly Manitowoc again)

Nov ’07- Joseph Ross (non exec), David McCulloch (ceo), Mike Cronk (non exec) all buy shares between 166p and 186p.

In my opinion these recent purchases are not significant in terms of the number of existing shares held, but they do show a continuation of a significant behavioural pattern, from which you and I should be able to benefit.

Maybe sufficiently to be able to buy a new kitchen!

Enodis Kitchen

Last Thursday, November 21st, the three amigos at Michael Page International (MPI), CEO Ingham, CFO Puckett and MD Dumon, stepped in to buy back shares they had sold only 7 1/2 months earlier at twice the price.

Steve Ingham, CEO of MPI Stephen Puckett, CFO of MPI

They each bought 170,000 shares at 280p. Puckett and Ingham sold on April 10th around 147,000 shares at 560p each. Dumon sold 428,000 shares on April 10th and May 4th at between 560p and 580p.

I suggested in my post on November 14th that, following the move by Nelson, CFO of SThree (STHR), who bought £100k worth of shares at 211p having sold in November 2006 at 372p, we were likely to see a positive share price move in the sector.

Look for more news from SThree next Thursday, when they give us a ‘pre close trading update’. This is likely to be positive for the Recruitment Sector overall.

Five non exec directors of Royal Bank of Scotland (RBS) last week bought shares at between 403p and 423p. They increased their shareholdings by a significant amount, by between 25 and 150%, and put in between £40k and £495k of their own money.

For a bank which is supposedly sitting on possible losses of several billion pounds this is certainly interesting behaviour. It also signals to me that the market has oversold RBS in anticipation of the disclosure of these losses.

The top for RBS was signalled in March by Finance Director Whittaker, who sold almost £500k of shares in his employer at prices almost 75% higher than today.  I believe last Thursday and Fridays purchases signal a buying opportunity.

If I look at the sector overall, I find the biggest director buying in Barclays (£600k) and RBS (£2.2m) over the last 30 days. Selling has been in HSBC (Non exec Hughes Hallett almost £1m) and Standard Chartered (Chairman Davies £1.5m) both in mid October. Bothy these stocks rank amongst the best performers of the month, down only 11% and 2% over the last thirty days, while RBS and Barclays rank amongst the worst performers, bar Northern Rock, down 28% and 27% over the same period.

If I were a betting man, I’d switch out of STAN and HSBC into BARC and RBS ahead of write down disclosures below what the market now anticipates. And I’d also be looking for more news about something potentially much more serious, contagion of a US and European slowdown to Asian economies.

Add to Technorati Favorites

Prefer to get emails? Click here

RSS Find us on twitter.com/directorsdeals

  • An error has occurred; the feed is probably down. Try again later.

twitter

February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728